Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
M1 Kliniken AGMKLNF 92 5-Year Yield-on-Cost % is 0.00 as of Jul. 22, 2026. GuruFocus rates MKLNF with a GF Score™ of 92/100 and a GF Value™ of $10.20. The stock has 2 warning signs investors should review. Among 69 Medical Distribution companies, M1 Kliniken AG ranks better than 79.71% on this metric.
M1 Kliniken AG's yield on cost for the quarter that ended in Dec. 2025 was 0.00.
The historical rank and industry rank for M1 Kliniken AG's 5-Year Yield-on-Cost % or its related term are showing as below:
During the past 12 years, M1 Kliniken AG's highest Yield on Cost was 3.78. The lowest was 1.73. And the median was 2.72.
MKLNF's 5-Year Yield-on-Cost % is not ranked *
in the Medical Distribution industry.
Industry Median: 3.66 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
M1 Kliniken AG (OTCPK:MKLNF) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
M1 Kliniken AG 5-Year Yield-on-Cost % Related Terms
MKLNF vs MCK, CAH, COR: 5-Year Yield-on-Cost % Comparison
For the Medical Distribution subindustry, M1 Kliniken AG's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
M1 Kliniken AG 5-Year Yield-on-Cost % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, M1 Kliniken AG's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where M1 Kliniken AG's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of M1 Kliniken AG is calculated as
M1 Kliniken AG (MKLNF) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 22, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on M1 Kliniken AG and its competitors. Over the past decade, M1 Kliniken AG's 5-Year Yield-on-Cost % has ranged from 1.73 to 3.78. According to the industry distribution chart, M1 Kliniken AG ranks #14 out of 69 companies in the Medical Distribution industry, placing it in the top 20.3%.
Is M1 Kliniken AG's 5-Year Yield-on-Cost % too high?
M1 Kliniken AG's current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 1.73 to a high of 3.78. Based on the distribution chart, M1 Kliniken AG ranks #14 out of 69 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, M1 Kliniken AG has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does M1 Kliniken AG's 5-Year Yield-on-Cost % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, M1 Kliniken AG ranks #14 out of 69 companies for 5-Year Yield-on-Cost %. This places M1 Kliniken AG in the top 20% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 3.66. Historically, M1 Kliniken AG's own 5-Year Yield-on-Cost % has ranged from 1.73 to 3.78 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Distribution company?
The median 5-Year Yield-on-Cost % among Medical Distribution companies is 3.66, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on M1 Kliniken AG and its competitors. For the Medical Distribution industry, the median 5-Year Yield-on-Cost % is 3.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. M1 Kliniken AG's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M1 Kliniken AG stock overvalued right now?
M1 Kliniken AG (MKLNF) has a current 5-Year Yield-on-Cost % of 0.00. The stock's GF Value™ is $10.20, compared to a current price of $11.73 — trading 15% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. M1 Kliniken AG's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For M1 Kliniken AG (MKLNF), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is M1 Kliniken AG (MKLNF) Overvalued in 2026?
Based on GuruFocus' analysis, M1 Kliniken AG stock appears to be overvalued.
The current stock price of $11.73 is trading 15% above its estimated GF Value™ of $10.20.
Key valuation signals for MKLNF:
5-Year Yield-on-Cost %: 0.00
GF Value™: $10.20 vs. price of $11.73 (15% above fair value)
No single metric tells the full story. See the MKLNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
M1 Kliniken AG operates in the growing market of aesthetic medicine and plastic surgery and provides aesthetic medical treatments in the self-pay segment. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical, and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. The majority of its revenue is derived from the Trade segment.
92GF Score
Get the complete analysis for MKLNF
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MKLNF has been successfully added to your 
